RxDoctor Payments Data

Nicole Grilli, PA

Physician Assistant · Hartford, CTNPI 1710908694

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 515 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 59 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,958in general payments, 2019–2025

Across 515 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • AstraZeneca$717
  • GSK$472
  • Lilly USA, LLC$345
  • Johnson & Johnson$282
  • plus $4K from 53 others

What the payments were for

  • Food & beverage$8,86799%
  • Education$911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie117$1,574
Novo Nordisk75$1,099
AstraZeneca37$717
GSK25$472
Lilly USA, LLC16$345
Johnson & Johnson14$282
Otsuka America Pharmaceutical, Inc.13$275
Astellas Pharma US Inc12$274
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$273
Dexcom, Inc.11$229
Phathom Pharmaceuticals, Inc.22$228
Vanda Pharmaceuticals Inc.10$209
Exact Sciences10$208
Pfizer12$207
Corcept Therapeutics4$196
Amgen11$172
Boehringer Ingelheim8$166
Lundbeck LLC8$140
Novartis6$135
E.r. Squibb & Sons, L.L.C.7$133
Merck6$108
Idorsia Pharmaceuticals US Inc6$100
Abbott6$99
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$98
Takeda Pharmaceuticals U.S.A., Inc.4$88
Sanofi-aventis U.S. LLC4$82
Sunovion Pharmaceuticals Inc.5$82
Amneal Pharmaceuticals LLC4$75
Bayer3$69
Resmed Corp1$66
Shield Therapeutics Inc3$58
Eisai Inc.3$53
Sumitomo Pharma America, Inc.3$52
Kowa Pharmaceuticals America, Inc.3$45
Cequr Corporation1$42
Valinor Pharma, LLC2$39
Ardelyx, Inc.2$39
Insightec,inc1$35
Embecta Corp.1$35
Soleno Therapeutics, Inc.1$28
Scilex Pharmaceuticals Inc.1$24
Seqirus USA Inc1$23
Corium, LLC1$23
Almatica Pharma LLC1$22
Teva Pharmaceuticals USA, Inc.1$20
Xeris Pharmaceuticals, Inc.1$20
Antares Pharma, Inc.1$19
Otsuka Pharmaceutical Development & Commercialization, Inc.1$19
Biohaven Pharmaceuticals, Inc.1$17
Axsome Therapeutics, Inc.1$16
Inspire Medical Systems, Inc.1$16
Paratek Pharmaceuticals, Inc.1$16
Amarin Pharma, Inc.1$16
Currax Pharmaceuticals LLC1$15
Avanir Pharmaceuticals, Inc.1$14
Nabriva Therapeutics, PLC1$14
Watermark Medical, Inc.1$14
Collegium Pharmaceutical, Inc.1$14
Mylan Specialty L.p.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,958 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Medicare billing

Part B allowed, 2024
$19,243
Medicare patients
66
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$30,366
EliquisApixaban14$12,665
VascepaIcosapent Ethyl11$3,884
Albuterol Sulfate HfaAlbuterol Sulfate60$1,373
Ventolin HfaAlbuterol Sulfate13$718
Atorvastatin Calcium77$635
Omeprazole29$543
Paroxetine Hcl19$496
Metoprolol Succinate26$470
Pantoprazole Sodium48$456
Losartan Potassium77$425
Rosuvastatin Calcium42$424
Amlodipine Besylate54$380
Levothyroxine Sodium43$361
Gabapentin27$354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,099$30,36627 claims
PfizerEliquis$207$12,66514 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$75$36143 claims
Almatica Pharma LLCSertraline Hcl$22$26428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.

Other physician assistant in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →